ATTACHMENT 13- LEXINGTON VAMC BLOODBORNE PATHOGEN EXPOSURE MANAGEMENT PLAN.pdf

PDF 5 MB Posted

Attached to
Q522-- Mobile CT Lung Cancer Screening Federal contract opportunity
Solicitation number
36C24924R0075_0003
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9

About this file

This is a Bloodborne Pathogen Exposure Management Plan (MCP 111-02) for the Lexington VA Health Care Systems in Kentucky, effective May 26, 2020 through May 30, 2025. The plan outlines protocols for managing exposure to bloodborne pathogens among employees, trainees, residents, volunteers, contractors, and visitors.

The document details specific procedures for exposure incidents, including immediate washing of exposure sites, reporting requirements, and medical evaluation protocols. Key elements include: post-exposure prophylaxis regimens for HIV exposure (specifying Raltegravir 400mg twice daily plus Truvada once daily as the preferred regimen), testing requirements for hepatitis B and C exposures, and follow-up procedures lasting up to one year. The plan assigns specific responsibilities to various roles including the Occupational Health Physician, Occupational Health Nurse, Laboratory Information System, Emergency Department Physician, and Clinical House Supervisor. It includes detailed flowcharts for managing exposures during regular hours (0730-1600) and after hours, with specific contact information and procedures for both VA paid employees and non-employees.

View the file

Other files for this federal contract opportunity

Other files attached to Q522-- Mobile CT Lung Cancer Screening, newest first.
File Type Posted
36C24924R0075 0003.pdf PDF
36C24924R0075 0002-Amendment 2.pdf PDF
ATTACHMENT 3 - CONFLICT OF INTEREST CERTIFICATION STATEMENT.pdf PDF
ATTACHMENT 8- JAMES H. QUILLEN OCCUPATIONAL SAFETY POLICY.pdf PDF
ATTACHMENT 5 - ONBOARDING FLOWCHART.pdf PDF
ATTACHMENT 10- JAMES H. QUILLEN EMERGENCY NOTIFICATION PLAN.pdf PDF
ATTACHMENT 14- JAMES H. QUILLEN PARKING AND TRAFFIC REGULATIONS.pdf PDF
ATTACHMENT 16-POTENTIAL AREAS OF SERVICE.pdf PDF
ATTACHMENT 1 - QUALITY ASSURANCE SURVEILLANCE PLAN.pdf PDF
ATTACHMENT 2 - CONTRACTOR CERTIFICATION IMMIGRATION AND NATIONALITY ACT OF 1952 AS AMENDED.pdf PDF
ATTACHMENT 4-SCA WD NO. 2015-4641 REV 21 AND WD NO. 2015-4683 REV NO. 26.pdf PDF
ATTACHMENT 6- JAMES H. QUILLEN PATIENT IDENTIFICATION POLICY.pdf PDF
ATTACHMENT 7- JAMES H. QUILLEN ABUSE OF PATIENTS MEMO.pdf PDF
ATTACHMENT 9- JAMES H. QUILLEN DISCLOSURE OF ADVERSE EVENTS TO PATIENTS.pdf PDF
ATTACHMENT 15- LEXINGTON VAMC PARKING AND TRAFFIC REGULATIONS.pdf PDF
36C24924R0075_1.pdf PDF
36C24924R0075 0001-Amendment 1.pdf PDF
ATTACHMENT 11- LEXINGTON VAMC PATIENT IDENTIFICATION MEMO.pdf PDF
ATTACHMENT 12- LEXINGTON VAMC PATIENT ABUSE NEGLECT SEXUAL TRAUMA AND THREATS OF VIOLENCE POLICY.pdf PDF
Show all 19

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

BLOODBORNE PATHOGEN EXPOSURE MANAGEMENT PLAN

MCP 111-02

Lexington VA Health Care Systems Lexington, Kentucky 40502

Rescinded Document:

None

Signatory Authority: Effective Date:

Lexington VA Healthcare Systems Director

May 26, 2020

Recertification Date:

Responsible Owner: May 30, 2025 Infection Control Nurse

1. POLICY

To provide a safe and healthful work environment for our staff. The Bloodborne Pathogen Exposure Management Plan is a key document to assist us in implementing and ensuring compliance with the OSHA standard, thereby protecting our staff. A copy of the exposure plan and the OSHA standard is accessible to all staff on the Lexington Intranet and on the Public Drive/+lnfection Control folder. To manage individuals (for example employees, trainees, residents, volunteers, contractors, visitors) exposed to bloodborne pathogens. This includes evaluation, testing, and post-exposure prophylaxis, if indicated for individuals exposed to bloodbome pathogens.

2. JUSTIFICATION

Individuals with percutaneous, conjunctiva!, non-intact skin or mucus membrane contact with patient blood/body fluids are encouraged to report the exposure and go immediately or as soon as possible to occupational health or the emergency department for post exposure evaluation, treatment and follow-up. Further management will depend on employee vs. non-employee status (see attachment A). Abnormal testing results of the source or exposed person are communicated to that individual by the ordering practitioner/surrogate. Occupational Safety and Health Administration's (OSHA) Bloodborne Pathogen Standard, 29 CFR 1910.1030 "Occupational Exposure to Bloodborne Pathogens". (Also, see the Bloodborne Pathogen Exposure Prevention Plan

MCP).

3. RESPONSIBILITIES

a. Occupational Health Physician

(1) Conduct initial evaluation, testing and prophylaxis during normal work hours (07:30 to 16:00).

(2) Follow-up evaluations, monitoring of laboratory tests during the period of chemoprophylaxis and post-treatment follow-up for a period of up to one year.

File details come from the government source that posted it. Updated .